Werewolf Therapeutics (HOWL) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free HOWL Stock Alerts $5.05 -0.52 (-9.34%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWerewolf Therapeutics, Inc. (NASDAQ:HOWL) to Post Q2 2024 Earnings of ($0.40) Per Share, HC Wainwright Forecastsamericanbankingnews.com - May 9 at 6:36 AMWerewolf Therapeutics: Buy Rating Affirmed Amid Promising Clinical Advancements and Pipeline Potentialmarkets.businessinsider.com - May 8 at 5:17 AMWerewolf Therapeutics (NASDAQ:HOWL) Stock Rating Reaffirmed by JMP Securitiesamericanbankingnews.com - May 8 at 4:40 AMWedbush Reiterates Outperform Rating for Werewolf Therapeutics (NASDAQ:HOWL)americanbankingnews.com - May 8 at 4:40 AMWerewolf Therapeutics (NASDAQ:HOWL) Stock Rating Reaffirmed by HC Wainwrightamericanbankingnews.com - May 8 at 4:40 AMThe Analyst Verdict: Werewolf Therapeutics In The Eyes Of 4 Expertsmarkets.businessinsider.com - May 6 at 7:27 PMWerewolf Therapeutics (NASDAQ:HOWL) Earns "Outperform" Rating from Wedbushmarketbeat.com - May 6 at 5:22 PMBuy Rating Affirmed for Werewolf Therapeutics Amid Promising Financials and Anticipated Clinical Updatesmarkets.businessinsider.com - May 6 at 7:29 AMHOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Misses Revenue for Q1 2024investorplace.com - May 3 at 3:18 PMHowl: Leonardo DiCaprio Working on Live-Action Movie Told From a Dog and Wolf’s Perspectiveyahoo.com - May 3 at 1:09 PMWerewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updateglobenewswire.com - May 3 at 7:00 AMMy patient thinks he’s a werewolf: 10 years as an NHS psychiatristyahoo.com - May 2 at 8:23 AMHowling Deal: Great Wolf Lodge offers $84 specialmsn.com - May 1 at 8:23 AMWhy Do Dogs Howl? 6 Top Reasons Your Dog Howlsmsn.com - April 30 at 7:20 AMWerewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetingglobenewswire.com - April 24 at 10:05 AMWerewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meetingfinance.yahoo.com - April 23 at 8:09 AMWerewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meetingglobenewswire.com - April 23 at 8:00 AMBuy Rating Affirmed for Werewolf Therapeutics on Promising PREDATOR Platform Prospects and Strong Pipeline Potentialmarkets.businessinsider.com - April 19 at 3:40 PMShort Interest in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Grows By 9.3%marketbeat.com - April 15 at 2:25 PMWhy Howl's turn-based tactics are ideal for mobilemsn.com - April 12 at 9:07 AMWerewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meetingglobenewswire.com - April 5 at 4:30 PMWerewolf Therapeutics: In The Hunt For Success In The Cytokine Spaceseekingalpha.com - April 4 at 6:16 PMWerewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meetingglobenewswire.com - April 4 at 4:30 PMWerewolf Therapeutics (NASDAQ:HOWL) Now Covered by Analysts at JMP Securitiesmarketbeat.com - April 3 at 8:18 AMWerewolf Therapeutics (NASDAQ:HOWL) Trading 2.9% Higher marketbeat.com - March 21 at 2:22 AMWerewolf Therapeutics Inc HOWLmorningstar.com - March 15 at 8:02 PMBuy Rating Affirmed for Werewolf Therapeutics with Anticipated Surge on WTX-124 Phase 1 Data Releasemarkets.businessinsider.com - March 11 at 10:45 AMWerewolf Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 9 at 2:42 PMBuy Rating Reiterated for Werewolf Therapeutics Amid Promising INDUKINE Platform Developmentsmarkets.businessinsider.com - March 7 at 9:35 PMHOWL Stock Earnings: Werewolf Therapeutics Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 7 at 5:03 PMRecap: Werewolf Therapeutics Q4 Earningsbenzinga.com - March 7 at 2:35 PMWerewolf Therapeutics, Inc.: Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 7 at 8:23 AMWerewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 7 at 7:00 AMHOWL Mar 2024 2.500 putfinance.yahoo.com - March 6 at 10:50 PMWerewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 6 at 8:00 AMWerewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2024globenewswire.com - March 5 at 4:30 PMWerewolf Therapeutics, Inc. (HOWL)finance.yahoo.com - February 27 at 11:05 PMWerewolf Therapeutics Stock (NASDAQ:HOWL), Short Interest Reportbenzinga.com - February 21 at 11:51 PMDo wolf reintroduction programs restore ecosystems? It's not that simple, researchers sayyahoo.com - February 20 at 5:10 PMCool Video Captures Rare Sight of Wolf Pack Trekking Through Deep Snow in Chinayahoo.com - February 20 at 5:10 PMWolves howl in different accentsmsn.com - February 12 at 6:57 PMWerewolf Therapeutics Expands Offering with $25M Stock Salemsn.com - February 10 at 8:04 AMWatch mesmerizing footage of gray wolf running in the snow captured by Colorado rancheryahoo.com - February 8 at 1:07 PMHC Wainwright Weighs in on Werewolf Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:HOWL)marketbeat.com - February 6 at 8:17 AMThe Wolf Moon will howl at five planets above Boise this week. Here’s how to view them allnews.yahoo.com - January 24 at 4:26 PMHowl review - If you go into the woods todaymsn.com - January 19 at 3:12 PMMesmerizing Video Captures Harmonious Howls of Wolf Pack Serenading in the Snowmsn.com - January 17 at 5:06 PMWerewolf Therapeutics, Inc.: Werewolf Therapeutics Provides Business Update and Highlights 2024 Strategic Outlookfinanznachrichten.de - January 8 at 9:47 AMWerewolf Therapeutics Provides Business Update and Highlights 2024 Strategic Outlookfinance.yahoo.com - January 8 at 9:47 AMWerewolf Therapeutics, Inc.: Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directorsfinanznachrichten.de - January 5 at 8:53 AM Get Werewolf Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide HOWL Media Mentions By Week HOWL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HOWL News Sentiment▼0.030.58▲Average Medical News Sentiment HOWL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HOWL Articles This Week▼151▲HOWL Articles Average Week Get Werewolf Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aldeyra Therapeutics News 2seventy bio News 23andMe News Foghorn Therapeutics News Immutep News Veru News Pyxis Oncology News Conduit Pharmaceuticals News AC Immune News Emergent BioSolutions News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HOWL) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
